• FirefoxInstall the new Firefox »
  •  Dow Down 0.23% Nasdaq Down 0.27%

    AbbVie Inc. (ABBV)

    -NYSE
    57.27 Down 0.95(1.63%) Mar 26, 4:00PM EDT
    |After Hours : 57.51 Up 0.24 (0.42%) Mar 26, 7:28PM EDT
    Add to Portfolio
    Prev Close:58.22
    Open:58.00
    Bid:56.87 x 100
    Ask:58.09 x 100
    1y Target Est:69.08
    Beta:1.66
    Earnings Date:Apr 23 - Apr 27 (Est.)
    Day's Range:57.22 - 58.09
    52wk Range:45.50 - 70.76
    Volume:10,853,908
    Avg Vol (3m):11,615,600
    Market Cap:91.28B
    P/E (ttm):52.06
    EPS (ttm):1.10
    Div & Yield:2.04 (3.40%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ABBVDown 1.63%91.28B
    MRKDown 1.13%163.48B
    NVSDown 0.80%238.81B
    PFEDown 0.41%209.36B

    Key Statistics

    Forward P/E (1 yr):11.62
    P/S (ttm):4.65
    Ex-Dividend Date:13-Apr-15

    Analysts

    Annual EPS Est (Dec-15) :4.32
    Quarterly EPS Est (Mar-15) :0.85
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):0.86

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products include HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-o... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback